205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.06%
Revenue growth under 50% of NXPI's 5.87%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.38%
Gross profit growth at 50-75% of NXPI's 7.37%. Martin Whitman would question if cost structure or brand is lagging.
10.11%
EBIT growth below 50% of NXPI's 190.74%. Michael Burry would suspect deeper competitive or cost structure issues.
9.21%
Operating income growth under 50% of NXPI's 190.74%. Michael Burry would be concerned about deeper cost or sales issues.
7.23%
Net income growth under 50% of NXPI's 295.24%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.98%
EPS growth under 50% of NXPI's 305.20%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.94%
Diluted EPS growth under 50% of NXPI's 291.52%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.06%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
62.24%
OCF growth at 75-90% of NXPI's 74.66%. Bill Ackman would demand better working capital management or cost discipline.
76.64%
FCF growth under 50% of NXPI's 212.90%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
101.87%
10Y revenue/share CAGR 1.25-1.5x NXPI's 87.91%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
27.36%
5Y revenue/share CAGR at 50-75% of NXPI's 40.16%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.00%
3Y revenue/share CAGR above 1.5x NXPI's 8.33%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
336.00%
10Y OCF/share CAGR above 1.5x NXPI's 213.38%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
164.88%
5Y OCF/share CAGR above 1.5x NXPI's 82.20%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
79.90%
3Y OCF/share CAGR above 1.5x NXPI's 37.66%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
578.69%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
118.39%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
70.62%
Below 50% of NXPI's 464.46%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
24.55%
Equity/share CAGR of 24.55% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-7.32%
Negative 5Y equity/share growth while NXPI is at 675.11%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.78%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
602.36%
Dividend/share CAGR of 602.36% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
155.50%
Dividend/share CAGR of 155.50% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.39%
3Y dividend/share CAGR of 102.39% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.44%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.34%
Negative asset growth while NXPI invests at 1.87%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.17%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.10%
Debt shrinking faster vs. NXPI's 16.32%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.26%
We increase R&D while NXPI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
1.45%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.